pubmed.ncbi.nlm.nih.gov/40158703/
We show 6wks of selective androgen receptor modulator (SARM-RAD140) treatment increases lean mass/bone mineral density and reduces inflammation in male, not female mice. Still it did not reduce frailty. Longer term SARMS exposure may be needed to reduce frailty
18.04.2025 00:07
👍 3
🔁 1
💬 0
📌 0